Present indications for direct myocardial revascularization

Israel Journal of Medical Sciences
|February 1, 1975
PubMed

Insights

Direct myocardial revascularization is superior for most angina pectoris cases. A proposed classification of myocardial ischemia aids treatment decisions, alongside ergometric studies and cine coronary angiography for patient selection.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Coronary arteriosclerosis presents complex treatment challenges.
  • Current indications for direct myocardial revascularization require clear definition.
  • A standardized classification of myocardial ischemia is lacking, hindering treatment analysis.

Purpose of the Study:

  • To discuss current indications for direct myocardial revascularization.
  • To propose a universally acceptable classification of myocardial ischemia.
  • To analyze the advantages and disadvantages of medical versus surgical treatments.

Main Methods:

  • Review of current medical and surgical treatment strategies for coronary arteriosclerosis.
  • Proposal of a new classification system for myocardial ischemia.
  • Evaluation of ergometric studies and cine coronary angiography in patient selection.

Main Results:

  • Ergometric studies are valuable for differentiating between medical and surgical treatment.
  • Cine coronary angiography is essential for accurate diagnosis and surgical candidate selection.
  • Surgical therapy for coronary arteriosclerosis demonstrates significant success.

Conclusions:

  • A proposed classification of myocardial ischemia is crucial for treatment analysis.
  • Direct myocardial revascularization is superior to medical treatment for most forms of angina pectoris.
  • Accurate diagnostic tools like cine coronary angiography improve surgical outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...